Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Metrion Biosciences
Metrion Biosciences
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
IMPACT CKD model reveals the escalating toll of chronic kidney disease
The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Isospec Analytics launches biomolecular analysis technology to identify unknown molecules
The novel technology optimises the identification process of unknown molecules compared to mass analysis
Building strong foundations for a resilient and planet-friendly future
Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector
The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Metrion Biosciences enhances High Throughput Screening services
Access to Enamine's compound collection enables greater flexibility and efficiencies in screening and target identification
Finance
Metrion Biosciences closes £3.7m new equity financing
Funds to be used to expand Metrion’s Cambridge UK laboratories and to enhance scientific and commercial capabilities
Regulatory
Metrion launches Good Laboratory Practice hERG screening service
This means the company is therefore able to offer GLP compliant hERG ion channel screening services to the global life sciences community
Drug Delivery
Metrion Biosciences launches HTS capability
“The launch of our HTS capability adds another layer of depth to our ion channel drug discovery services and complements our automated and conventional electrophysiology services"
Research & Development
Metrion and Bioqube to collaborate on drug discovery project
The project aims to identify novel ion channel inhibitors for autoimmune diseases
Finance
Metrion appoints Vice President for US Commercial Operations
The appointment is planned to support the company's next phase of growth in the US
Finance
Metrion Biosciences expands into Cambridge headquarters
The 12,000 sqft facility more than doubles the company’s laboratory space
Subscribe now